Brain-Computer Interface Device Makers Must Consider Accessibility And Deployability
This article was originally published in The Gray Sheet
Executive Summary
Brain-computer interface device makers should consider customer accessibility and clinicians’ ability to deploy the BCI system to get to market, Medtronic technology director says at an FDA meeting. New brain-machine interface include products to help paraplegics walk and people with tremors to grasp tools used in daily life.
You may also be interested in...
Thought-Controlled Prosthetics Get US FDA 'Leapfrog' Treatment
A new "leapfrog" draft guidance from the US agency addresses implanted brain-computer interface prosthetic devices, and, specifically, the information sponsors should be prepared to submit for pre-submissions meetings and investigational device exemptions.
FDA Seeks Feedback On Brain-Computer Interface Devices For Amputees
The agency has scheduled a November workshop on brain-computer interface devices to discuss scientific, clinical and regulatory considerations for firms designing neuroprostheses that work with the central nervous system to help restore motor capabilities in paralyzed and amputee patients. The meeting could inform development of a draft guidance.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.